| Gene-environment interactions in Alzheimer's disease: a potential path to precision medicine A Eid, I Mhatre, JR Richardson Pharmacology & therapeutics 199, 173-187, 2019 | 112 | 2019 |
| Consequences of lead exposure, and it’s emerging role as an epigenetic modifier in the aging brain A Eid, N Zawia Neurotoxicology 56, 254-261, 2016 | 104 | 2016 |
| Pomegranate ellagitannin-gut microbial-derived metabolites, urolithins, inhibit neuroinflammation in vitro NA DaSilva, PP Nahar, H Ma, A Eid, Z Wei, S Meschwitz, NH Zawia, ... Nutritional Neuroscience 22 (3), 185-195, 2019 | 91 | 2019 |
| Developmental lead exposure and lifespan alterations in epigenetic regulators and their correspondence to biomarkers of Alzheimer's disease A Eid, SW Bihaqi, WE Renehan, NH Zawia Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2, 123-131, 2016 | 87 | 2016 |
| Pomegranate extract modulates processing of amyloid-β precursor protein in an aged Alzheimer’s disease animal model A H Ahmed, G M Subaiea, A Eid, L Li, N P Seeram, N H Zawia Current Alzheimer Research 11 (9), 834-843, 2014 | 54 | 2014 |
| Developmental exposure to lead (Pb) alters the expression of the human tau gene and its products in a transgenic animal model M Dash, A Eid, G Subaiea, J Chang, R Deeb, A Masoud, WE Renehan, ... Neurotoxicology 55, 154-159, 2016 | 34 | 2016 |
| Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1 AL Green, L Zhan, A Eid, H Zarbl, GL Guo, JR Richardson Neuropharmacology 125, 189-196, 2017 | 27 | 2017 |
| Lead exposure and tau hyperphosphorylation: an in vitro study SW Bihaqi, A Eid, NH Zawia Neurotoxicology 62, 218-223, 2017 | 22 | 2017 |
| Tolfenamic acid: a modifier of the tau protein and its role in cognition and tauopathy JK Chang, A Leso, GM Subaiea, A Lahouel, A Masoud, F Mushtaq, ... Current Alzheimer research 15 (7), 655-663, 2018 | 19 | 2018 |
| Histone acetylation maps in aged mice developmentally exposed to lead: epigenetic drift and Alzheimer-related genes A Eid, SW Bihaqi, C Hemme, JM Gaspar, RP Hart, NH Zawia Epigenomics 10 (5), 573-583, 2018 | 15 | 2018 |
| Importance of tau in cognitive decline as revealed by developmental exposure to lead K Wright, SW Bihaqi, A Lahouel, A Masoud, F Mushtaq, A Leso, A Eid, ... Toxicology letters 284, 63-69, 2018 | 12 | 2018 |
| Effects of DDT on amyloid precursor protein levels and amyloid beta pathology: Mechanistic links to Alzheimer’s disease risk A Eid, I Mhatre-Winters, FM Sammoura, MK Edler, R von Stein, ... Environmental health perspectives 130 (8), 087005, 2022 | 9 | 2022 |
| Sex and APOE genotype alter the basal and induced inflammatory states of primary microglia from APOE targeted replacement mice I Mhatre-Winters, A Eid, Y Han, K Tieu, JR Richardson International Journal of Molecular Sciences 23 (17), 9829, 2022 | 8 | 2022 |
| Epigenetic regulation of the ontogenic expression of the dopamine transporter AL Green, A Eid, L Zhan, H Zarbl, GL Guo, JR Richardson Frontiers in Genetics 10, 1099, 2019 | 4 | 2019 |
| Sex and APOE genotype alter the basal and induced inflammatory states of primary astrocytes from humanized targeted replacement mice I Mhatre-Winters, A Eid, Y Han, K Tieu, JR Richardson ASN neuro 15, 17590914221144549, 2023 | 2 | 2023 |
| P1‐153: DDT exposure increases levels of the amyloid precursor protein, amyloid beta, and proinflammatory factors: mechanistic links to alzheimer's disease risk A Eid, JR Richardson, C White III, DC German Alzheimer's & Dementia 15, P295-P295, 2019 | 1 | 2019 |
| Pharmacoepigenetics and Pharmacoepigenomics of Valproate in Neurodegenerative Disease A Eid, JR Richardson Pharmacoepigenetics, 801-816, 2019 | | 2019 |
| In Vitro Approaches for Studying Amyloids and Neurotoxicity A Eid, SE May, N Zawia, JL Camberg | | 2018 |
| Epigenetic pathways involved in response to lead (Pb) exposure in the aging brain: Relevance to Alzheimer's disease A Eid | | 2016 |
